Wall Street’s biggest banks are quietly positioning themselves for what could be the most lucrative stretch of IPO activity in the history of equity capital markets.
JPMorgan (JPM) analysts argue that investors are broadly underestimating the financial upside that a wave of massive public offerings could deliver to major banks in the coming months.
SpaceX has lined up JPMorgan, Bank of America (BAC), and 21 other banks for its anticipated IPO, with Goldman Sachs (GS) and Morgan Stanley (MS) taking lead positions on the deal.
Underwriting fees for the SpaceX IPO alone could total as much as $1 billion, according to some estimates, representing a staggering payday even by Wall Street standards.
The sheer scale of the listing has prompted SpaceX to negotiate an unusually slim fee structure, potentially below 0.75%, far beneath the typical 4% to 7% range that banks charge for standard IPO underwriting work.
For context, when Goldman Sachs and Morgan Stanley led Medline’s $7.2 billion listing in December, the two firms together took home more than a third of the $156.5 million in total fees generated.
Beyond SpaceX, JPMorgan and its rivals are aggressively competing for lead roles in the anticipated public offerings of AI model makers Anthropic and OpenAI, both expected later this year.
If all three landmark listings come to market within a single calendar year, it would represent the largest fee concentration in the history of equity capital markets for any group of banks.
The cumulative capital demands of these offerings are also drawing attention from market analysts tracking liquidity conditions across broader financial markets.
Raising $75 billion for SpaceX alone requires that capital to come from somewhere, contributing to potential selling pressure in speculative and risk assets across portfolios.
Should Anthropic and OpenAI follow SpaceX to market later this year as expected, total fresh equity supply could reach somewhere between $150 billion and $195 billion by autumn.
That volume of new issuance would test the market’s capacity to absorb supply without triggering broader disruptions in equity valuations or fund flows.
Goldman Sachs, JPMorgan, and Morgan Stanley are named as advisers across multiple mega-IPO transactions, giving the three firms an unusually dominant grip on the deal pipeline.
For bank investors, the argument from JPMorgan analysts is straightforward: the fee potential embedded in this IPO cycle is not yet fully reflected in current share price valuations across the sector.
